Sensorion (STU:RFM) Short Interest


STU:RFM Sensorion SA STU:RFM
29 GF Score
Price €0.23
! 1 Warning Sign
View Full Analysis

What is Sensorion Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:RFM vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Sensorion's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sensorion Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sensorion's Short Interest distribution charts can be found below:

* The bar in red indicates where Sensorion's Short Interest falls into.


STU:RFM
29GF Score
Sensorion SA STU:RFM
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensorion Business Description

Other Exchanges ALSEN:France
Address 375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
29GF Score

Get the complete analysis for STU:RFM

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.23
Price